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Abstract.  Ankyrin is a well characterized membrane 
skeletal protein which has been implicated in the an- 
chorage of specific integral membrane proteins to the 
spectrin-based membrane skeleton in a number of sys- 
tems. In this study, the organization of ankyrin was 
examined in lymphocytes in relation to T cell func- 
tion. Light and electron microscope immunolocaliza- 
tion studies revealed extensive heterogeneity in the 
subcellular distribution of ankyrin in murine tissue- 
derived lymphocytes. While ankyrin can be localized 
at the lymphocyte plasma membrane, it can also be 
accumulated at some distance from the cell periphery, 
in small patches or in a single discrete, nonmembrane- 
bound structure. Double immunofluorescence studies 
demonstrated that ankyrin colocalizes with spectrin 
and with the signal transducing molecule protein ki- 
nase CB (PKCB) in tissue-derived lymphocytes, sug- 
gesting a functional association between these mole- 
cules in the lymphocyte cytoplasm. In addition, T 
lymphocyte activation-related signals and phorbol ester 
treatment, both of which lead to PKC activation, 
cause a rapid translocation of ankyrin, together with 
spectrin and PKC/~, to a single Triton X-100-insoluble 
aggregate in the cytoplasm. This finding suggests a 
mechanism for the reported appearance of PKC in the 
particulate fraction of cells after activation: activated 
lymphocyte PKCB may interact with insoluble 
cytoskeletal elements like ankyrin and spectrin. Fur- 
ther evidence for a link between the subeellular orga- 
nization of these proteins and PKC activity is provided 
by the observation that inhibitors of PKC activity 
cause their concomitant redistribution to the cell pe- 
riphery. The dynamic nature of lymphocyte nnkyrin 
and its ability to accumulate at sites distant from the 
plasma membrane are properties which may be unique 
to the lymphocyte form of the molecule. Its colocal- 
ization with PKCB in the lymphocyte cytoplasm, to- 
gether with its redistribution in response to physiologi- 
cal signals, suggests that structural protein(s) may play 
a role in signal transduction pathways in this cell type. 
Our data support the conclusion that ankyrin is not 
solely involved in anchorage of proteins at the plasma 
membrane in lymphoid cells. 
KYRIN is a structural protein that was initially isolated 
from red cell membranes, where it links the cyto- 
plasmic domain of the erythrocyte anion exchanger 
(band 3) to the spectrin-based membrane cytoskeleton. It is 
now known that erythrocyte  ankyrin is a member of a family 
of closely related proteins that are found in many cell types 
(for reviews see Bennett and Lambert, 1991; Bennett, 1992). 
These proteins appear to play  roles as adapters  between 
specific integral membrane proteins and the spectrin skele- 
ton. Cell surface proteins that have been shown to interact 
with ankyrin include the Na+/K+-ATPase  and the amiloride- 
sensitive sodium channel in kidney, the voltage-dependent 
sodium channel in brain and at the neuromuscular  junction, 
and the ankyrin-binding glycoproteins (ABGPs) in brain (for 
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review see Bennett,  1992). Based on studies in various sys- 
tems, it has been proposed that ankyrin functions either in 
the initial  targeting  of membrane proteins  to  specjaliTed 
areas of the cell surface or in maintaining local concentra- 
tions of integral membrane proteins once the membrane do- 
mains have assembled  (for example see Nelson and Ham- 
merton, 1989; Bennett and Lambert, 1991). 
The forms of ankyrin found in erythrocytes  and brain are 
the best characterized members of the family. They consist 
of three independently folded domains:  an 89-95-kD NH2- 
terminal membrane binding domain, a 62-kD domain (with 
an apparent molecular  mass of  72 kD on SDS gels) that binds 
to spectrin, and a 50-55-kD COOH-terminal regulatory do- 
main. The 89-95-kD NH2-terminal membrane binding do- 
main of these ankyrins is almost entirely composed of 22 
tandem repeats of 33 amino acids which are responsible, in 
the erythrocyte, for the high affinity interaction of ankyrin 
with the anion exchanger (Davis and Bennett,  1990). These 
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to 33-residue motifs found in a number of otherwise widely 
divergent proteins including yeast cell cycle  control proteins, 
membrane proteins that regulate cell differentiation during 
development, and mammalian transcriptional regulators (for 
reviews see Michael), and Bennett,  1992; Nolan and Balti- 
more, 1992). It has been proposed that these repeats are in- 
volved in molecular recognition. 
A 72-kD protein with similarities to erythrocyte ankyrin 
has been identified  and characterized in a  mouse T-lym- 
phoma cell line (BW5147) (Bourguignon et al.,  1986). Its 
ankyrin-like properties include the ability to bind purified 
erythrocyte  spectrin, localization on the cytoplasmic side of 
the plasma membrane, and cross-reactivity with anti-eryth- 
rocyte and anti-brain ankyrin antibodies. In addition, it has 
a pI and a peptide mapping pattern similar to those of the 
72-kD proteolytic fragment of erythrocyte ankyrin. This 
72-kD ankyrin-like protein was found to be tightly  asso- 
ciated with a major T lymphoma plasma membrane glyco- 
protein, GP85 (Pgp-1, CD44), with which it co-caps upon 
ligand-induced receptor cross-linking  (Bourgnignon et al., 
1986; Kalomiris and Bourguignon,  1988). Based on these 
findings, and on the observation  that lymphocyte spectrin 
(fodrin)  is also  localized  at the cell periphery and co-caps 
with cross-linked  surface molecules (Levine and W'fllard, 
1983; Nelson et al., 1983; Bourgnignon et al., 1985), it has 
been proposed that the 72-kD ankyrin-like  protein is respon- 
sible for linking GP85 to spectrin and other cytoskeletal ele- 
ments  which are  involved  in  lymphocyte cap  formation 
(Bourguignon  et al.,  1986). While the physiological  sig- 
nificance of the capping  process is not understood, these 
findings suggest that lymphocyte ankyrin can interact with 
membrane components in a manner analogous to that ob- 
served in the erythrocyte  and in various non-erythroid cells 
(see above). 
Studies  from  our  laboratory,  however, focusing  on  the  role 
of  the cytoskeleton  in the physiological  response of  tissue- 
derived lymphocytes to antigen-induced  activation  signals, 
have revealed an unexpected complexity in the subcellular 
organiTation of the ankyrin-binding protein spectrin in lym- 
phoid tissues (Repasky et al., 1984; Pauly et al., 1986; Black 
et al., 1988). Lymphocyte  spectrin is not invariably localized 
at the plasma membrane but can be found at several intracel- 
lular locations.  Increasing evidence indicates that this het- 
erogeneity reflects the dynamic nature of lymphocyte spec- 
trin and its ability to redistribute  within the cytoplasm in 
response to lymphocyte activation-related  signals or other 
stimuli involved in lymphocyte maturation and/or function 
(Lee et al.,  1988; Gregorio et al.,  1992). Recent immu- 
nolocalization  and biochemical analysis  have revealed  that 
an important component of the T  cell receptor-activated 
signal transduction pathway, the enzyme protein kinase C 
(PKC)  ~/3II, is associated (either directly or indirectly) with 
lymphocyte  spectrin suggesting involvement of  this cytoskel- 
etal protein in signal transduction pathways. Since ankyrin 
is a spectrin-binding protein which is thought to mediate the 
interaction of cell surface molecules with the underlying 
membrane cytoskeleton (see above), we have examined its 
organization in lymphocytes exhibiting different patterns of 
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spectrin  distribution,  particularly  in  those  where spectrin  is 
not  associated  with the  plasma membrane. It  was also  of  in- 
terest  to  determine the  relationship  of  ankyrin  to  the  redistri- 
bution of spectrin  and PKC/3 in response to activation- 
related  signals. 
In  the  present  study,  the subcellular  organization  of  anky- 
rin  was examined in  untreated  and activated  lymphocytes to 
gain  insight  into  its  role  in  lymphocyte function.  Ankyrin is 
shown to  exhibit  heterogeneous subcellular  localization  pat- 
terns,  reflecting  its dynamic responses to PKC activation- 
related  signals.  Our studies  suggest  that  ankyrin and other 
membrane  cytoskeletal  components may carry out novel 
functions  in  lymphoid cells.  The significance  of  our  findings 
is discussed  in terms of  the reported  properties  of ankyrin 
in other  cell  types. 
Materials and Methods 
Cells 
The T cell hybridoma, DO-11.10, was generously provided by Drs. P. Mar- 
rack and J. Kappler (National Jewish Center for Immunology and Respira- 
tory Medicine, Denver, CO) and grown as previously described (White et 
ai., 1983). Tissue lymphocytes were isolated from lymph node  s taken from 
2-3-too-old female Baib/c mice. An enriched population of T iymphocytes 
was obtained by passage of lymph node cell suspensions over nylon wool 
(Julius et ai.,  1973). Purification was confirmed by immunoiluorescence 
microscopy, using fluorescein isothiocyanate-conjugated anti-Thy 1.2 anti- 
bodies CICN Biomedicals,  Inc.,  Costa Mesa,. CA) to identify T lympho- 
cytes. 
Antibodies 
The anti-chicken  erythrocy~ ankyrin (goblin) antiserum used in this study 
was  prepared  by  immunizing  rabbits  with  antigen  isolated  from two- 
dimensional gels. The rabbit and goat anti-chicken  erythrocyte c~-spectrin 
antisera have been characterized previously (Black et ai., 1988; Lee et ai., 
1988; Grngorio et ai., 1992). The anti-PKC~-specific monoclonal antibody 
(anti-PKC/3 1.3: GIBCO-BRL, Gaithersburg, MD) has been characterized 
extensively  in  our  system  (Grngorio  et  ai.,  1992). The  pan-reactive 
anti-mouse ~,~ T cell receptor monoclonal antibody, H57-597 was gener- 
ously provided by Dr.  R. Kubo (Cytel,  La Julia,  CA).  Fluorescein  and 
rhodamine-isothiocyanate  conjugated  antisera  were purchased  from ICN 
Biomedicais  Inc.  Horseradish  peroxidase-conjugated  antisera  were pur- 
chased from Boehringer Mannheim Corp. (Indianapolis, IN) for immuno- 
blot analysis and from ICN Biomedicals Inc. for electron microscopy. 
Gel Electrophoresis and Western Blotting 
For SDS-PAGE, chicken and mouse erythrocyte membranes were prepared 
as previously  described  (Granger  et el.,  1982; Bennett,  1983). Human 
erythrocyte ankyrin was isolated  by  the procedure of  Bennett  and Stenbuck 
(1980). For immunoblot analysis of ankyrin in T lymphocytes, conditions 
were optimized to reduce proteolysis (Bennett,  1983). Isolated cells were 
preincubated for 90 min in 10 mM diisopropylfluorophosphate  0DWP) in 
culture medium, and then washed with ice-cold PBS containing 5 mM Na- 
p-tosyl-L-arginine methyl ester (TAME), 1 mM phenylmethylsulfonyl fluo- 
ride (PMSF), 2 ~g ml  -~ pepstatin A, 1O ~tM leupeptin,  1 mM EDTA, and 
10 mM DIFP. Samples were solubilized in hot SDS-sample buffer, boiled 
for 3 min, subjected to 10% SDS-PAGE (Laemmli,  1970), and transferred 
to nitrocellulose paper (Bennett and Davis, 1981). The nitrocellulose sheets 
were incubated and washed as described previously (Gregorio et ai., 1988). 
Anti-ankyrin  antiserum  was diluted  1:500 and the pemxidase-conjngated 
secondary  antibody  was diluted  1:1000. 4-cldoro-l-napthol  dissolved  in 
methanol (3 mg m1-1) and diluted 1:5 with TBS containing 0.005% H202 
was used to visualize the peroxidase activity. 
Indirect lmmunofluorescence 
Isolated lymphocytes were prepared  for immunofluorescence stAinin~ as 
previously described (Repasky et al., 1984). When localizing both spectrin 
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rum albumin in PBS for 30 rain at 37°C to minimize nonspecific binding 
of the antibodies. Cells were stained with goat anti-a-spectrin antiserum 
(diluted 1:50 in PBS), followed by fluorescein-conjugated sheep anti-goat 
IgG.  The coverslips were then incubated with rabbit anti-ankyrin antiserum 
(1:25 in PBS) and rhodamine-conjugated goat anti-rabbit IgG. Identical 
results were obtained using an alternative protocol involving the following 
antibodies:, goat anti-~-spectrin  antiserum, rhodaminc-conjngated donkey 
anti-goat IgG, rabbit anti-ankyrin antiserum and fluorescein-conjugated 
donkey anti-rabbit IgG. To localize both ankyrin and PKC/~ in the same 
cells, isolated T lymphncytes were probed with mouse anti-PKC/~  antibod- 
ies (7 pg ml  -I) followed by fluorescein-conjngated sheep anti-mouse IgG. 
The coverslips were then incubated in rabbit anti-ankyrin antiserum, fol- 
lowed by rhodamine-conjugated goat anti-rabbit  IgG. For all experiments, 
identical results were obtained using an isotype-specific rabbit anti-PKC/~H 
peptide antiserum which was generously provided by Dr. A. Fields (Case 
Western Reserve, Cleveland, OH; Hocevar and Fields,  1991). 
In some experiments, ceils were treated with a cytoskeletal extraction 
buffer (CSK) containing 1% Triton X-100 for 5 rain at 4°C (Greenberg and 
Edelman,  1983). The extracted cells were then washed twice with CSK 
buffer without Triton 3:-100, twice with PBS, and then fixed for 20 rain in 
PBS/4% formaldehyde. CSK-extracted cells were immunostained as de- 
scribed above. 
The immunostalned coverslips were analyzed using an Olympus BM-2 
microscope; micrographs were taken using Tri-X or T-Max (400 ASA) film 
(Eastman  Kodak  Co.,  Rochester,  NY).  The  percentage  of cells  with 
cytoskeletal aggregates was quantified by examining a minimum  of  200 ceils 
per group. Each value represents the mean +  SEM of a minimum  of three 
experiments. 
Ultmstructural lmmunocytochemical Localization  of 
Ankyrin and Spectrin 
Lymph nodes isolated from Balb/c mice were fixed in periodate-lysine- 
paraformaldehyde fixative (PIP) (McLean and Nakane, 1974) for 3.5 h and 
cryoprotected overnight in 0.1 M phosphate buffer, pH 7.4, containing 60% 
sucrose. The tissue was quick frozen in liquid nitrogen; 25-30-pm sections 
were cut on a cryostat (AO HistoSTAT, Reichart Scientific Instruments, 
Buffalo, NY) at -20°C and subsequently thawed in 60% sucrose/PBS. The 
free-floating sectious  were incubated tycernight  in anti-ankyrin antiserum 
(1,15, diluted  in PBS/0.1% BSA/0.005% saponin).  Washes, incubations 
in secondary antibody, visualization of antibody binding sites, and process- 
ing for electron microscopy were carried out as described (Black et al., 
1988). Control samples treated with preimmune serum showed no specific 
staining. 
The protocol for the ultrastructural localization of spectrin in cultured 
lymphocytes has been described in detail previously (Black et al., 1988). 
For localization of ankyrin in DO-11.10 ceils, cultured lymphncytes were 
fixed with PLP and immunostained for ankyrin as described for lymphoid 
tissue sections (see above), except that the fixed cells were extracted with 
0.01% saponin/PBS and incubated in  primary antiserum for 2 h. Before fixa- 
tion in 2 % glutaraldehyde, the cells were incubated in suspension; after this 
step all incubations were performed on pelleted cells. 
Activation of  lsolated Murine Lymphocytes 
Isolated T lymphocytes were washed in fresh medium and stimulated at a 
final concentration of 2 x  106 m1-1. The protein kinase C activator, phor- 
bol 12-myristate 13-acetate (PMA) (Sigma Chemical Co., St. Louis, MO) 
was added directly to the cell suspension to obtain a final concentration of 
10 ng m1-1. Solvent was used as a control in each experiment. T cells were 
activated using an immobilized (H57-597) pan-reactive anti-mouse a,~ T 
ceil receptor (TcR) monoclonal antibody (Kubo et al., 1989). Briefly, 24- 
well culture plates were coated with protein  A (Sigma Chemical Co.) (100 
/~g ml  -l in PBS) overnight, at 4°C. The wells were washed and 250 ~l of 
undiluted H57-597 culture supernatant was added for 2 h at 4°C, followed 
by additional washes. Cells added to uncoated plates and to plates coated 
with protein A alone were used as controls. T cells were also activated using 
methods which bypass the TcR; i.e., 10 ~,g ml  -l concanavalin A (Con A) 
plus 50 ng m1-1 PMA. 
Lymphocyte activation was confirmed using a standard proliferation as- 
say; 70 h after treatment, 0.5 pC [3H]TdR (Dupont-NEN, Boston, MA) 
was added to 2  x  105 ceils in 300 ~1 of medium and the ceils were har- 
vested 6 h later. Incorporated radioactivity was determined by scintillation 
counting. Data are expressed as mean incorporation of [3H]TdR into T 
cells. Values in cpms are representative of four experiments done in tripli- 
cate. Each value represents the mean +  SEM. 
•  Protein Kinase C lnhibitors 
Lymph node T cells were plated at a density of 2  x  10  ~ cells ml  -l and 
treated with I0 ~M staumsporine for 30 rain (ICN Biomedicals, Inc.), 100 
pM H-7 for 30 min (Seikagaku America Inc., Rockville, MD), or 0.5 pM 
calphostin C for 1 h (Kamiya Biomedical Co., Thousand Oaks, CA) before 
processing for immunofluorescence microscopy. A wide range of inhibitor 
concentrations were tested (50--400 pM H-7, 1-100/~M staurosporine and 
0.05-5/~M  calphostin C). Inhibitors were titrated based on the degree of 
cytoskeletal protein translocation and viability. All final concentrations of 
inhibitors used were within the range of reported doses required for inhibi- 
tion of PKC. Solvent was used as a control in each experiment. 
Results 
Immunoblot Analysis of  Lymphocyte Ankyrin 
In  this  study,  an  antibody  generated  in  rabbits  against 
chicken  erythrocyte  ankyrin  (goblin;  isolated  from  two- 
dimensional gels)  was  used to  characterize  T  lymphocyte 
ankyrin with regard to  its subceUular distribution and re- 
sponse to signals involved in lymphocyte activation. Use of 
this  antibody  in Western blot analysis  revealed  a  260-kD 
band in a  chicken erythrocyte preparation,  a  215-kD band 
in a  mouse erythrocyte preparation,  and a  215-kD band in 
a  sample  of purified  human erythrocyte  ankyrin (Fig.  1, 
lanes 1, 2, and 3, respectively). These results are consistent 
with reported molecular weights for ankyrin as observed on 
SDS-gels in these tissues (Bennett and Stenbuck,  1979; Yu 
and Goodman, 1979; Luna et al., 1979; Alper et al., 1980). 
The same antiserum detected a 72-kD band as well as a 215- 
k.D band in a sample enriched for T lymphocytes (Fig. 1, lane 
4). The relative proportions of the lymphocyte 215- and 72- 
kD  bands varied  significantly from  experiment  to experi- 
ment.  In all experiments the 72-kD band was predominant 
(see also: Bourguignon et al.,  1986). However, when condi- 
tions were optimized to reduce proteolysis and electropho- 
retic-transfer was carried out under conditions which facili- 
lqgure L Western blot analy- 
sis of murine T  lymphocytes 
using  rabbit  anti-chicken 
erythrocyte  ankyfin  antise- 
rum  reveals  cross-reactive 
bands of 215 and 72 kD. Sam- 
ples included chicken erythro- 
cyte membranes (lane 1), mu- 
fine  erythrocyte  membranes 
(lane  2),  a  preparation  of 
purified  human  erythrocyte 
ankyfin 0ane 3),  and an en- 
riched  population  of  Balb/c 
lymph  node  T  lymphocytes 
(lane 4).  The  antiserum de- 
tected  a  260-kD  band  in 
chicken  erythrocy~  mem- 
branes  (goblin),  a  215-kD 
cross-reactive band in routine and human erythrocytes, and cross- 
reactive bands of 215 and 72-kD in murine T  lymphocytes. The 
numbers in the left margin represent the relative molecular mass 
standards (kD). 
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215-kD band could be detected (Fig.  1, lane 4). 
Ankyrin Distribution in Isolated T Lymphocytes: 
Comparison with the Distribution of  Lymphocyte 
Spectrin and PKCf3 
To examine the subeellular distribution of ankyrin in lym- 
phocytes, T  cells isolated from murine lymph nodes were 
stained by indirect immunofluorescence  using the polyclonal 
anti-ankyrin  antiserum described above. Extensive heteroge- 
neity was observed in the localization of ankyrin in these 
cells (Fig. 2, a and c). While some cells showed ankyrin uni- 
formly distributed at the plasma membrane or restricted to 
a distinct membrane-associated "cap; others showed the pro- 
tein accumulated in small patches or in a single large aggre- 
gate in the cytoplasm. In addition, depending on the plane 
of focus, a  filamentous star-like staining pattern could be 
seen in the cytoplasm of every cell (e.g., Fig. 2 c, open ar- 
row; for a particularly clear example of this staining pattern 
see Fig. 7 C,i). The specificity of the ankyrin staining pat- 
terns,  including the filamentous pattern described above, 
was confirmed in competition experiments using purified 
erythrocyte ankyrin.  A  50-fold molar  excess  of purified 
ankyrin included in the primary antibody incubation step 
eliminated all staining (data not shown). 
To determine whether ankyrin colocaiizes with spectrin 
and PKC/~ in T  lymphocytes, double immunofluorescence 
studies were performed. Fig. 2  demonstrates that ankyrin 
colocalizes precisely with each of these proteins, except in 
the case of the star-like staining pattern which appears to be 
unique to ankyrin (see Discussion). 
The heterogeneity in the subcellular distribution of lym- 
phocyte ankyrin and its ability to accumulate in an intracel- 
lular aggregate were unexpected based on its tight associa- 
tion  with  the  plasma  membrane  in  other  cell  types.  To 
characterize further the nature of lymphocyte ankyrin, and 
to gain insight into the basis for the heterogeneity in its dis- 
tribution, in vivo and in vitro model systems were used for 
(a) detailed examination of its organiTation at the ultrastruc- 
tural level of resolution and (b) analysis of its organization 
in relation to lymphocyte function. 
Ultrastructurrd Localization of  Lymphocyte Ankyrin 
Ultrastructural immunoperoxidase localization of ankyrin in 
sections of murine lymph node revealed that cytoplasmic ag- 
gregates of ankyrin can occur several microns from the cell 
Figure 2. Subcellular distribu- 
tion  of  ankyrin  in  isolated 
T  lymphocytes: comparison 
with the distribution of lym- 
phocyte spectrin and PKC/3. 
Untreated  freshly  isolated 
murine T  lymphocytes were 
stained for ankyrin using rab- 
bit  anti-chicken  erythrocyte 
ankyrin (goblin) antiserum (a 
and  c)  as  described in Ma- 
terials  and  Methods.  Dou- 
ble immunofluorescence  tech- 
niques were used to compare 
the localization  of  ankyrin and 
spectrin (S) (a and b, respec- 
tively)  and  of  ankyrin  and 
PKC~ (c and d, respectively) 
in the same cells. The subcel- 
lular  distribution of ankyrin 
varied  considerably  among 
tissue  T  cells:  while  some 
cells  showed the  expected 
"ring" of immunofluorescence 
staining  at the plasma mem- 
brane  (small  arrow),  others 
showed  a  membrane-asso- 
ciated  polar  cap  or  several 
small  patches  at  the  mem- 
brane  and/or  in  the  cyto- 
plasm (arrowhead), and many 
showed all of  the protein accu- 
mulated in a single large cyto- 
plasmic  aggregate  (/arge  ar- 
rows).  In addition,  all  cells 
exhibited a filamentous star- 
like staining pattern for ankyrin (open arrow). Ankyrin was found to colocalize precisely with spectrin and PKCO in T cells, except in 
the case of the filamentous staining pattern which was displayed only by ankyrin. Note, that c and d (middle, right  side) contain a con- 
taminating cell which does not demonstrate colocalization of PKC/~ with ankyrin. Bar, 10 pM. 
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localization of ankyrin in murine lymphocytes 
in situ.  PLP-fixed sections of routine lymph 
node were immunostained for ankyrin at the 
ultrastructural level using a pre-embedding  im- 
munoperoxidase technique. Immunoprecipitate 
can be seen in the cytoplasm of several lym- 
phocytes, at some distance from the plasma 
membrane (arrowheads). Many lymphocytes 
contain a discrete aggregate  of  ankyrin near the 
nucleus or Golgi apparatus. Note the numerous 
membranous  vesicles present within the region 
demonstrating ankyfin immunoprecipitate.  The 
aggregate  is  generally  oval or  spherical in 
shape, although it can  be  horseshoe-shaped 
(arrows). Bar, 1 #M. 
surface (Fig.  3,  a  and b).  The aggregates were generally 
spherical or oval in shape although, as previously observed 
for lymphocyte  spectrin aggregates (Black et al., 1988), they 
could also be horseshoe-shaped (Fig. 3 a). Numerous mem- 
branous vesicles were present within the area demonstrating 
ankyrin immunoprecipitate. No staining was observed at the 
plasma membrane; this is likely to be due to sensitivity limi- 
tations of the pre-embedding immunostaining technique and 
the overall low levels  of ankyrin in lymphocytes (data not 
shown) since, as shown in Fig. 2, many lymphocytes do ex- 
press ankyrin at the cell periphery. 
The aggregate of ankyrin was further characterized in the 
DO.11-10  cell  line,  a  major  histocompatibility complex- 
restricted,  functionally mature  T  lymphocyte hybridoma 
specific for ovalbumin (Kappler et al., 1981; Hasldns et al., 
1983).  These  cells constitutively and homogeneously ex- 
press a large cytoplasmic aggregate of spectrin (Black et al., 
1988; Lee et al., 1988). The basis for the constitutive expres- 
sion of the aggregate phenotype (one of the distribution pat- 
terns of spectrin known to occur in situ) in these long-term 
cultured cells, which exhibit transformed or leukemic prop- 
erties,  is  unknown.  However,  they  were  useful  for  im- 
munolocalization studies at the light and electron micro- 
scope level of resolution to assess the relationship between 
the ankyrin and spectrin aggregates. 
Using immunofluorescence localization techniques, anky- 
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spectrin in DO-11.10 T cell hyhridoma 
cells  at the fight  and electron micro- 
scope levels of resolution.  (A) (a) An- 
kyrin immunofluorescence in untreated 
DO-11.10 cells.  A  large aggregate of 
ankyrin can be seen in the cytoplasm 
of every cell (arrow).  Ultrastructural 
immunoperoxidase localization of an- 
kyrin in DO-11.10 cells.  As shown in 
b and c (arrows),  the immunoprecipi- 
tate is detectable only at some distance 
for the cell surface,  in close associa- 
tion with the trans-region of the Golgi 
apparatus  (G). Aggregates of  ankyrin, 
which are usually oval or spherical  in 
shape (1-2/zm across), contain numer- 
ous small membranous vesicles (d and 
e).  N,  nucleus.  Note the  absence of 
ankyrin staining  at the plasma mem- 
brane  (b-e).  (B) (a) Spectrin immu- 
nofluorescence  in untreated  D0-11.10 
cells.  Like ankyrin, spectrin is accu- 
mulated in a focal aggregate in the cy- 
toplasm of  every cell (arrow) and is ab- 
sent  from  the  cell  periphery  (b-d). 
Ultrastructural immunoperoxidase lo- 
calization  of  spectrin  in  DO-11.10 
cells.  Reaction product (arrows)  can 
be seen accumulated near the trans-region of  the Golgi apparatus and centriolar complex (C). The spectrin aggregate is also oval or spherical 
in shape, measures 1-2/~m across, and is packed with small membranous vesicles.  These micrographs show that the ankyrin and spectrin 
aggregates in lymphocytes are indistinguishable  with regard to shape, size and subcellular  localization.  Bars: (A,a and B,a) 10/zm; (A,b-d 
and B,b-d)  1 I~m. 
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gate in DO-11.10 cells (Fig. 4 A,a; compare with Fig. 4 B,a). 
Double immunofluorescence  studies  revealed  that  spectrin 
and ankyrin are co-localized in these cells (data not shown). 
Ultrastructural  immunoperoxidase  staining  revealed  that, 
like spectrin (Fig. 4 B,b--d), ankyrin is also accumulated in 
a discrete region  at one pole of the DO.11-10 cell, several 
microns from the cell surface and usually in close associa- 
tion with the centriolar complex and the trans-region  of the 
Golgi  apparatus  (Fig.  4  A,b-e).  Numerous  membranous 
vesicles of various sizes could be seen clustered within the 
ankyrin aggregate (Fig. 4 A,e, arrowheads); note that these 
vesicles were also present within the area stained for spectrin 
(Fig. 4 B~d). The location of the spectrin and ankyrin reac- 
tion product corresponds well to the location of the cytoplas- 
mic structure composed primarily  of a  fine meshwork of 
densely packed filaments, as observed by conventional thin- 
section microscopy (i.e., in the absence of immunoperoxi- 
dase staining,  data not shown; see Black et al.,  1988). The 
cytoskeletal aggregate was not membrane bound; however, 
it excluded most other cellular organelles.  Since  immuno- 
peroxidase localization of either spectrin or ankyrin resulted 
in identical  staining  patterns,  we conclude that  the previ- 
ously characterized  structure in DO-11.10 cells that contains 
spectrin (Black et al.,  1988) also contains ankyrin. 
Ankyrin Is a Dynamic Molecule in Lymphocytes: 
Effects of  Activation-related Signals on T Lymphocyte 
Ankyrin Distribution 
The finding that ankyrin, spectrin and PKC/3 are colocalized 
in lymphocytes (see above), together with the observation 
that the distribution of lymphocyte speetrin can be altered by 
activation-related  signals (Lee et al., 1988; Gregorio et al., 
1992), led us to examine the effects of direct PKC stimulation 
and lymphocyte activation on the organization  of ankyrin in 
tissue-derived T lymphocytes. The phorbol ester PMA was 
used to stimulate PKC directly. Treatment of T lymphocytes 
with this agent resulted in a loss of the naturally  occurring 
heterogeneity  in lymphocyte ankyrin distribution  and a dra- 
matic reorganization  of this protein into a single large cyto- 
plasmic aggregate (compare untreated cells in Fig. 5, a and 
g with PMA-treated cells in Fig. 5, c and i). Although  not 
apparent  in the micrograph shown,  it should be noted that 
the filamentous star-like distribution  of ankyrin staining was 
unaffected by PMA treatment;  the significance of this local- 
ization was, therefore,  not addressed in this study (see Dis- 
cussion).  Within 5 rain of the addition of PMA, the fraction 
of ceils containing  an aggregate of ankyrin increased from 
~20 to 50 %, and reached >75 % within 30 rain. This strik- 
ing alteration in the distribution of ankyrin was accompanied 
by a coincident reorganization  of lymphocyte spectrin  (Fig. 
5, a-d) and PKC/~ (Fig.  5, g-j). 
To determine whether the cytoplasmic aggregates of anky- 
rin, spectrin and PKC/5  which appeared after PKC stimulation 
were formed from newly synthesized protein, tissue-derived 
T  cells  were  pretreated  with  10  /~g  ml-I  cycloheximide 
prior to the addition of PMA. Appearance of aggregates was 
not sensitive to this inhibitor  of protein synthesis (Table I), 
indicating  that they are formed by the translocation  of pre- 
existing protein.  This experiment  strongly  suggests that the 
movement  of ankyrin,  spectrin and PKC/5 within  the lym- 
phocyte cytoplasm is posttranslationally  regulated. 
Since  PKC has been shown  to be an important  second 
messenger triggered by activation of the T cell antigen recep- 
tor, we speculated that lymphocyte ankyrin may be function- 
ally linked to activation-induced  events. To investigate this 
hypothesis,  T  lymphocytes were activated  via the T  cell 
receptor (TcR) complex using an immobilized pan-reactive 
anti-mouse c~/3 T cell receptor-specific monoclonal antibody 
(H57-597; Kubo et al.,  1989) or by methods which bypass 
the TcR such as a combination of PMA and Con A. Activa- 
tion using either of these methods also resulted in a rapid and 
long-lasting  increase in the percentage of T cells containing 
large, coincident aggregates of ankyrin, spectrin and PKC/3 
(Fig. 5, e andf[TcR simulation];  Fig. 5, k and I [PMA plus 
Con A stimulation]). 
To examine the solubility  properties of aggregated  anky- 
tin, lymph nede-derived T lymphocytes were treated with 
a  Triton  X-100-contalning  cytoskeleton-stabilizing  buffer 
(CSK buffer) reported to extract the cytoplasm and leave be- 
hind the cytoskeleton, nucleus and some cytoskeleton-asso- 
ciated  proteins  (Greenberg  and  Edelman,  1983).  When 
freshly isolated T lymphocytes are treated with CSK, the 
majority of cells exhibited little or no staining  for ankyrin, 
spectrin  or PKCB (indicating  for example,  that membrane- 
associated ring-like  staining  is Triton X-100 soluble); how- 
ever, cytoplasmic aggregates  and membrane caps of these 
proteins were evident in some cells. In contrast, virtually all 
T  lymphocytes extracted  with CSK after PMA treatment 
exhibited  large  aggregates  of detergent-insoluble  ankyrin, 
spectrin and PKC/3 (Fig.  6). The percentage of control or 
PMA-treated T cells containing  these proteins in a cytoplas- 
mic aggregate was unaffected by CSK extraction,  suggesting 
that all aggregates  are Triton X-100 insoluble. 
Effects of  Protein Kinase C Inhibitors on Ankyrin 
Organization in T Lymphocytes 
The data described above suggest that  the organization  of 
lymphocyte ankyrin and spectrin is related to that of lympho- 
cyte PKC/3 and suggest that the presence of coincident cyto- 
plasmic aggregates of these proteins in situ may be indicative 
of physiological stimulation  of PKC. To gain further insight 
regarding the relationship between these proteins in lympho- 
cytes, the effects of several inhibitors of PKC on their organi- 
zation in murine T cells were examined.  Three PKC inhibi- 
tors were used for these studies including staurosporine,  H-7 
and calphostin C. Staurosporine and H-7 have been reported 
to act on the catalytic domain ofPKC (Nakadate et al., 1988; 
Hidaka et al., 1984), whereas the highly specific PKC inhib- 
itor, calphostin C interacts with the regulatory domain of the 
enzyme and inhibits the binding of diacylglycerol analogues 
(Kobayashi et al.,  1989). 
Treatment  of freshly isolated  tissue-derived T  lympho- 
cytes with any of the three inhibitors  resulted in an alteration 
of the naturally  occurring heterogeneity  in the distribution 
of ankyrin, spectrin  and PKC/3. Treatment  with staurospo- 
fine, H-7 or calphostin C resulted in a steady increase in the 
fraction of cells exhibiting ankyrin, spectrin and PKC/3 at the 
cell periphery and a decrease in the fraction of cells express- 
ing  cytoplasmic  aggregates  or  patches  of these  proteins 
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ment  or  activation of lymph 
node-derived  T  lymphocytes 
results  in  a  rapid  accumula- 
tion of ankyrin,  spectrin and 
PKC/3 in an intracellular ag- 
gregate.  T  lymphocytes were 
isolated  from  murine  lymph 
nodes by passage of cell sus- 
pensions  over  nylon  wool. 
Control and treated cells were 
double-stained  for  ankyrin 
and spectrin (,4) or for ankyrin 
and  PKC/5  (B)  using  indi- 
rect immunofluorescence tech- 
niques. Ankyrin immunofluo- 
rescence  is always  shown on 
the leit. Microgaphs show dis- 
tribution patterns  after treat- 
ment of cells for 20 rain.  (,4) 
(a and b) untreated T lympho- 
cytes; (c and d) T cells treated 
with  PMA  (10  ng  ml  -i)  to 
stimulate PKC directly; (e and 
f)  T  cells  activated  through 
the antigen receptor using an 
immobilized  pen-reactive  anti- 
mouse ,/5 TcR-specific mono- 
clonal anU~y (H57-597). (B) 
(g and h) untreated T lympho- 
cytes; (i and j) T cells treated 
with  PMA  (10  ng  ml-l);  (k 
and l) T cells activated using 
a  combination  of PMA  and 
Con A (50 ng ml  -I and 10/zg 
m1-1,  respectively).  Stimula- 
tion of lymphocyte PKC with 
phorbol ester or activation of 
T  cells  using  two  different 
methods resulted in rapid dis- 
appearance  of  the  naturally 
occurring heterogeneity in the 
distribution of ankyrin, spec- 
trin and PKC/3 in lymphocytes 
and accumulation of these pro- 
teins  in  a  large  cytoplasmic 
aggregate. Arm~ demonstrate 
colocalization  of proteins  in 
such aggregates. T cell activa- 
tion  was  confirmed  by mea- 
suring [3I-I]thymidine uptake: 
control no.  1 (no additions), 
653 +  358 cpm; control no. 2 
(protein  A  alone),  1,447  + 
210 cpm; H57-597 activated, 
77,076  ±  9,697  cpm;  and 
conA  plus  PMA  activated, 
333,311  +  10,790 cpm. Bar, 
10/~M. 
(compare Fig. 7, A-C with Fig. 2  [untreated control cells]). 
The  pattern  of membrane-associated  immunofluorescence 
staining differed, however, with the drug used. In T lympho- 
cytes treated with staurosporine (Fig. 7 A), all three proteins 
appeared to be accumulated in a crescent-shaped region near 
the plasma membrane (clearly distinct from the cytoplasmic 
aggregates of these proteins described above; see Figs. 5 and 
6),  whereas cells treated with H-7 generally exhibited uni- 
form or interrupted  rings of membrane-associated  fluores- 
cence staining (Fig. 7 B). Treatment of cells with calphosfin 
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the Translocation of Lymphocyte Ankyrin,  Spectrin, and 
PKCf3 in Murine  T Lymphocytes 
Treatment  Percent of cells with aggregates 
None  24  +  15.0 
CH  25  +  6.4 
PMA  85  +  5.3 
CH  +  PMA  91  +  6.1 
2 x  l0  s T cells mi-] were preincubated for 2 h in 15/~g ml  -t of cyelohexi- 
mide (a concentration  known to inhibit protein synthesis and to abrogate the 
capacity of IFN-~ to increase the focal distribution of spectrin in human 
leukemic B cells: Evans  et al., 1993), before  the addition of PMA. Cells were 
harvested  I  h  after stimulation and  processed for  immunofluorescence 
microscopy. Cell viability was assessed by trypan blue exclusion. The per- 
centage of cells with cytoskeletal aggregates  was quantified by examining a 
minimum of 200 cells per group. Each  value represents the mean 5: SEM of 
three experiments. 
C  resulted  in  an  increase  in  the  percentage  of cells  with 
plasma membrane-associated tings of fluorescence staining 
(Fig. 7 C). The fact that ankyrin, spectrin and PKC/~ under- 
went an  identical  reorganiTation  in  response  to  treatment 
with these inhibitors provides additional support for a func- 
tional association of these proteins in T  lymphocytes. 
Discussion 
The studies described in this report demonstrate that lym- 
phocyte ankyrin can be stably expressed  at some distance 
from the plasma membrane and can redistribute throughout 
the  cytoplasm in  response  to physiological T  lymphocyte 
activation-related signals. The extensive heterogeneity in the 
subcellular distribution of ankyrin both in lymphoid tissues 
and in lymphocyte cell lines reflects the dynamic nature of 
ankyrin.  While  ankyrin is  often  found at  the  lymphocyte 
plasma membrane, as would be expected for a  protein that 
can  link  cell  surface  macromolecules  to  the  underlying 
membrane cytoskeleton, it can also be found accumulated in 
a single large cytoplasmic aggregate or in numerous smaller 
patches in the cytoplasm or near the nucleus. Ultrastruetural 
localiTztion studies show that the cytoplasmic aggregate of 
lymphocyte ankyrin is a discrete, nonmembrane-bound struc- 
ture containing numerous minute membranous vesicles. It is 
Figure  6.  Colocalization  of 
ankyrin,  spectrin,  and PCKa 
in  a  Triton  X-lOO-insoluble 
aggregate induced in T  lym- 
phocytes by PMA treatment. 
Isolated T  cells were treated 
with PMA (I0 rig ml  -I) to in- 
duce  the  formation of tyro- 
skeletal  aggregates.  Treated 
cells were immob~  on AI- 
cian  blue-coated  coverslips, 
extracted  with a cytoskeleton 
stabilization  buffer containing 
1%  Triton  X-100,  fixed  in 
4%  formaldehyde  and  dou- 
ble-stained  for  ankyrin  and 
speetrin  (S) (a and b, respec- 
tively)  or ankyrin and PKC/3 
(c and d, respectively)  using 
indirect  immunottuorescence 
techniques.  Arrows  indicate 
detergent insoluble aggregates 
of  ankyrin, spectrin and PKC~. 
Bar,  10 tLM. 
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and can  frequently be seen in close association with the 
Oolgi apparatus.  Since,  in DO-11.10 cells, the cytoplasmic 
region stained by anti-ankyrin  antibodies is indistinguishable 
with regard to localization,  shape,  size and ultrastructural 
appearance from that observed using anti-spectrin  antibod- 
ies,  we conclude that ankyrin is a component of the pre- 
viously  characterized  "spectrin-rich  structure"  (Black  et 
all.,  1988). 
Since double immunofluorescence  studies presented here 
clearly show that aggregated and membrane-associated lym- 
phocyte ankyrin and  spectrin are always colocalized with 
PKC/3, we propose that PKC/5 is also a component of the 
cytoskeletal aggregate (also see Gregorio et al., 1992). This 
observation is of particular importance since PKC is an inte- 
gral component of the phosphatidylinositol cascade, which 
is involved in a wide range of cellular functions including T 
cell activation (Nishizuka,  1988). Stimulation of the antigen 
receptor leads to phosphatidylinositol  hydrolysis and libera- 
tion of two second messengers, one of which (diacylglycerol) 
is a potent activator ofPKC (Berridge and Irvine,  1989). The 
colocalization  of PKC/3 with cytoskeletal elements  in the 
lymphocyte cytoplasm suggests  the interesting  possibility 
that  structural  proteins play a  role in  signal  transduction 
mechanisms  in this cell type. 
Insight  regarding  the basis for the heterogeneity in lym- 
phocyte ankyrin distribution was obtained from examination 
of the effects of activation-related  signals on its subcellular 
organization  in T lymphocytes. These studies clearly dem- 
onstrated (a) the dynamic nature of lymphocyte ankyrin and 
(b) the relationship  between ankyrin subcellular distribution 
and PKC activity. Activation of PKC with the phorbol ester 
PMA or through activation of the T lymphocyte receptor (an 
event which has been shown to lead to PKC activation,  see 
review: Cambier,  1992) resulted in a rapid reorganization  of 
ankyrin  in  the lymphocyte cytoplasm.  Ankyrin,  together 
with spectrin and PKC/3, accumulated in a single cytoplas- 
mic aggregate in virtually all treated cells. The rapidity with 
which the changes occurred (<5 min), together with their in- 
sensitivity  to  cycloheximide  treatment,  was indicative  of 
redistribution  of existing protein. Conversely, ankyrin, spec- 
trin  and  PKC/~ were  found  to  move  coincidentally  to 
membrane-associated locations in response to inhibitors  of 
the catalytic and regulatory domains of PKC, providing fur- 
ther evidence for a functional,  and perhaps also structural, 
association of these proteins in the lymphocyte cytoplasm. 
Moreover,  pretreatment with an inhibitor of the regulatory 
domain of PKC, calphostin C blocked the formation of cyto- 
plasmic aggregates  of ankyrin,  spectrin and PKCI5 in re- 
sponse to PMA treatment or TcR-mediated lymphocyte acti- 
vation (data not shown for ankyrin;  see Gregorio et al., 1992 
for data on spectrin and PKC/~). Together, these data suggest 
that the activity and/or the conformation of the enzyme are 
important  in maintaining  appropriate distribution  patterns 
for ankyrin, spectrin and PKC/3 in lymph node T cells. With 
regard to the movement of these proteins to the cell periph- 
ery in response to treatment with staurosporine or H-7, it 
should be noted that  these inhibitors  are known to affect 
other protein kinases  with sequence homology to PKC in 
their catalytic domain (Kobayashl et al.,  1989); hence,  the 
morphological  changes  observed as a  result of treatment 
with these agents may not be a direct effect of their inhibition 
of PKC activity. 
It is interesting  to note that while freshly isolated T cells 
contain several different populations of T cells (i.e., CD4  +, 
CD8-,  CD4-  CD8  +)  virtually  all  of the  cells  responded 
similarly  to treatment with activators  or inhibitors  of PKC 
activity with respect to the distribution  of ankyrin, spectrin 
and PKC~. In addition,  the results described above suggest 
that  the presence of a  cytoplasmic aggregate  of ankyrin, 
spectrin and PKC~ in T cells indicates the occurrence of an 
event involving activation  of PKC (specifically of the 15 iso- 
form), and thus provide a possible basis for one of the natu- 
rally occurring distribution  patterns observed for ankyrin in 
T lymphocytes in situ. 
Immunottuorescence  staining of aggregated ankyrin,  spec- 
trin,  and PKC~ in PMA-treated T lymphocytes was unaf- 
fected by exposure to a Triton-containing  cytoskeleton sta- 
bilization  buffer,  suggesting  that these proteins are part of 
a stable assembly of Triton-insohible  elements. Since activa- 
tion of PKC is generally reflected in its translocation  from 
the soluble to the operationally defined "particulate fraction  ~ 
of the cell (consisting of plasma membrane, other membra- 
nous compartments and cytoskeletal elements;  for review 
see Berry and Nishizuka,  1990),  it is possible that the ap- 
pearance of lymphocyte PKC/~ in the ~insoluble  fraction  ~ 
(also see Gregorio et al., 1992) after activation is the result 
of its direct or indirect  interaction  with detergent-insoluble 
cytoskeletal elements  such as ankyrin and spectrin. 
Immunofluorescence analysis of ankyrin distribution in T 
lymphocytes also revealed a filamentous  %tar-like " staining 
pattern  which appears to be independent  of spectrin and 
PKC/3. Although the basis for this "star-like ~ staining pattern 
is unknown, preliminary results  from double immunofluo- 
rescence studies indicate it coincides with that of lymphocyte 
tubulin (data not shown). This finding is of interest since (a) 
tubulin has been shown to bind ankyrin repeats in the NH~- 
terminal  domain of themolecule (i.e.,  the 89-95-kD do- 
main)  and (b) it has been suggested  that  ankyrin may be 
involved in mediating attachment of tubulin to certain intra- 
cellular  membranes  (Davis  and  Bennett,  1984;  Davis  et 
al.,  1991). 
Imrnunoblot  analysis  of ankyrin demonstrated the pres- 
ence of immunoreactive  bands of 215  and 72 led in mu- 
rine tissue lymphocyte preparations,  as previously seen in 
BW5147 cells (Bourguignon  et al.,  1986). The 72-kD band 
was predominant in all experiments,  even in the presence of 
a variety of protease inhibitors  (including  the calpain-1 in- 
hibitor calpeptin;  data not shown). In view of the sensitivity 
of erythrocyte ankyrin to proteolysis (Bennett and Stenbuck, 
1979), it is possible that the 72-kD band corresponds to the 
spectrin-binding  domain of ankyrin (Bennett,  1992)and is 
a degradation  fragment of the 215-kD band. In this regard, 
peripheral blood buff), coats have been reported to contain 
a protease to which ankyrin is particularly susceptible (Ben- 
nett, 1985). However, we cannot rule out the possibility that 
the 72-kD band represents a form of ankyrin that is present 
in  situ  and performs specific  function(s)  in lymphocytes, 
perhaps reflecting the dynamic properties of ankyrin in this 
cell type. The levels of the 215-kD band varied significantly 
from expe  "runent to experiment, as did the relative propor- 
tions of the two immunoreactive  forms of ankyrin detected. 
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observed after treatment with PKC activators or inhibitors, 
making it impossible to determine if their presence is related 
to the activation status of the enzyme. Further studies are re- 
quired  to  determine  whether  the  72-kD  immnnoreactive 
band  results  from  alternatively  spliced  messenger  RNA 
(Hall and Bennett, 1987;  Lux et al.,  1990), specific proteo- 
lyric processing (Davis et al.,  1989; Davis et al.,  1992) or 
is an artifact of sample preparation. 
In keeping with its function in molecular recognition (Ben- 
nett,  1992), lymphocyte ankyrin may participate in the for- 
marion of protein assemblies required  to perform specific 
functions at restricted subcellular sites. As mentioned above, 
signal transducing molecules like PKCB may come into con- 
tact with their substrates by associating directly or indirectly 
with cytoskeletal proteins such as ankyrin and spectrin.  In 
accordance with its structural role in erythrocytes and with 
its reported function in subcellular targeting events, ankyrin 
(perhaps in association with spectrin) is ideally suited to pro- 
vide the scaffolding necessary for the appropriate placement 
of PKCB for phosphorylation of molecules involved in T cell 
activation or other lymphocyte functions.  It is noteworthy 
that ankyrin has been shown to be a phosphoprotein (Alper 
et al.,  1980). To date, however, neither ankyrin nor spectrin 
has been identified as a substrate for PKC in any system, al- 
though  nonerythroid  /~G- and  BR-spectrins  have  recently 
been reported to contain domains with amino acid sequence 
homology to pleckstrin, a major protein kinase C substrate 
(Haslam et al.,  1993). 
The ability of lymphocyte ankyrin to be stably expressed 
as a detergent-insoluble aggregate at some distance from the 
plasma membrane and to relocate to discrete cytoplasmic 
sites may represent properties that are unique to the lympho- 
cyte form of the molecule. Interaction of lymphocyte ankyrin 
with proteins that are not always localized at the cell surface 
adds an additional complexity to this molecule. Our data on 
tissue derived lymphocytes suggest that previous work on the 
association  of ankyrin  with  a  glycoprotein  (gp85)  at  the 
plasma membrane in one T lymphoma cell line (Kalomiris 
and Bourguignon,  1988; Lokeshwar and Bourguignon,  1991; 
Bourguignon  et  al.,  1991)  may  underrepresent  the  sig- 
nificance of lymphocyte ankyrin's role in T cell function. Its 
relocation to a site at some distance from the lymphocyte 
plasma  membrane  in response to important  physiological 
(i.e., activation related) signals indicates that ankyrin is not 
solely involved in anchorage of proteins at the plasma mem- 
brane in lymphoid cells. 
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